Support legislation to reduce the price of asthma medications and therapies used to treat asthma and lung disorders such as COPD, including affordable inhalers and nebulizers.

Kweisi Mfume · Maryland · Democratic

policy impact 0.72 specificity 0.78 extraction confidence 79%

Occurrences

Congressman Mfume, Senator Alsobrooks Introduce Affordable Inhalers and Nebulizers Act ... the legislation will reduce the price of asthma medications and therapies used to treat asthma and lung disorders such as chronic obstructive pulmonary disease (COPD).

Mfume backed legislation aimed at making inhalers and nebulizers more affordable and lowering prices for asthma and COPD treatments.

Health | Representative Kweisi Mfume
primary · campaign_site · model gpt-5.4-mini

Evidence

Congressman Mfume, Senator Alsobrooks Introduce Affordable Inhalers and Nebulizers Act ... More specifically, the legislation will reduce the price of asthma medications and therapies used to treat asthma and lung disorders such as chronic obstructive pulmonary disease (COPD).

Mfume's official House issue page lists the inhalers and nebulizers bill and states it would reduce the price of asthma medications and COPD treatments.

partial same_term A for effort

Health | Representative Kweisi Mfume
primary · model gpt-5.4-mini · confidence 94%

Sponsor: Rep. Mfume, Kweisi [D-MD-7] (Introduced 09/10/2025) ... This bill has the status Introduced ... To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to reduce patient cost sharing for prescription drug inhaler products used to treat breathing disorders such as asthma and chronic obstructive pulmonary disease, and for other purposes.

Congress.gov shows Mfume sponsored the bill and that it was introduced, but it remained at the introduced stage rather than becoming law.

partial same_term A for effort

H.R. 5278 - Affordable Inhalers and Nebulizers Act of 2025
secondary · model gpt-5.4-mini · confidence 98%

The legislation will reduce the price of asthma medications and therapies used to treat asthma and lung disorders such as chronic obstructive pulmonary disease (COPD).

An official press release confirms Mfume publicly introduced the bill to lower costs for asthma and COPD medications and therapies.

partial same_term A for effort

Senator Alsobrooks, Van Hollen, and Congressman Mfume Introduce Affordable Inhalers and Nebulizers Act
secondary · model gpt-5.4-mini · confidence 96%

Congress.gov lists Rep. Kweisi Mfume as sponsor of H.R. 5278 and shows the bill was introduced and referred to House committees on 2025-09-10, with the tracker still showing status Introduced.

Official congressional record shows Mfume took the promised legislative step by introducing a bill targeting lower costs for inhaler products, but the measure remains only introduced and has not advanced to enactment.

unresolved same_term A for effort

Actions - H.R.5278 - 119th Congress (2025-2026): Affordable Inhalers and Nebulizers Act of 2025
secondary · model gpt-5.4-mini · confidence 99%

Assessments

delivered same_term

Mfume fulfilled the promise as framed: he promised to support legislation, and in the same federal House term he sponsored H.R. 5278, the Affordable Inhalers and Nebulizers Act of 2025, aimed at lowering patient cost sharing for inhalers, nebulizers, and treatments for asthma and COPD. The bill had not been enacted in the evidence provided, so this is not proof that medication prices were reduced, but enactment was not the core promised action; supporting and advancing such legislation was.

provider codex_cli · model gpt-5.5 · confidence 93%

delivered same_term

Mfume fulfilled the promise as framed because it was a commitment to support legislation, not necessarily to secure enactment. The evidence shows he sponsored/introduced H.R. 5278, the Affordable Inhalers and Nebulizers Act of 2025, during the same term, and the bill directly targets reduced patient costs for inhalers, nebulizers, asthma medications, and COPD-related therapies. The bill had not become law in the provided evidence, but legislative support itself was the promised action.

provider codex_cli · model gpt-5.5 · confidence 95%